Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 45 Records) |
Query Trace: Leukemia and SETBP1[original query] |
---|
Targeted next-generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS-R. American journal of hematology 2017 Sep . Tefferi Ayalew, Lasho Terra L, Patnaik Mrinal M, Saeed Lyla, Mudireddy Mythri, Idossa Dame, Finke Christy, Ketterling Rhett P, Pardanani Animesh, Gangat Nasee |
Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies. Journal of cancer research and clinical oncology 2017 Sep . Winkelmann Nils, Schäfer Vivien, Rinke Jenny, Kaiser Alexander, Ernst Philipp, Scholl Sebastian, Hochhaus Andreas, Ernst Thom |
Targeted next-generation sequencing identifies clinically relevant mutations in patients with chronic neutrophilic leukemia at diagnosis and blast crisis. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2017 Jul . Langabeer S E, Haslam K, Kelly J, Quinn J, Morrell R, Conneally |
Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia. American journal of hematology 2017 Mar . Patnaik Mrinal M, Barraco Daniela, Lasho Terra L, Finke Christy M, Reichard Kaaren, Hoversten Katherine P, Ketterling Rhett P, Gangat Naseema, Tefferi Ayal |
Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis. PloS one 2017 12 (2): e0171608. Shou Li-Hong, Cao Dan, Dong Xiao-Hui, Fang Qiu, Wu Ying, Zhang Yan, Fei Ju-Ping, Xu Bao-Li |
[The clinical characteristics, gene mutations and prognosis of chronic neutrophilic leukemia]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2017 Jan 38 (1): 28-32. Cui Y J, Jiang Q, Liu J Q, Li B, Xu Z F, Qin T J, Zhang Y, Cai W Y, Zhang H L, Fang L W, Pan L J, Hu N B, Qu S Q, Xiao Z |
Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia. Oncotarget 2017 Feb . Ouyang Yuan, Qiao Chun, Chen Yu, Zhang Su-Jia |
Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management. American journal of hematology 2018 Aug 93 (4): 578-587. Elliott Michelle A, Tefferi Ayal |
SETBP1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome. Pathology, research and practice 2018 Mar . Yao Xin-Yu, Zhou Jing-Dong, Yang Jing, Zhang Wei, Ma Ji-Chun, Wen Xiang-Mei, Yao Dong-Ming, Xu Zi-Jun, Wu De-Hong, He Pin-Fang, Qian Jun, Lin Jia |
MLL-rearranged acute myeloid leukemia: Influence of the genetic partner in allo-HSCT response and prognostic factor of MLL 3' region mRNA expression. European journal of haematology 2018 2 100 (5): 436-443. Burillo-Sanz Sergio, Morales-Camacho Rosario M, Caballero-Velázquez Teresa, Carrillo Estrella, Sánchez Javier, Pérez-López Olga, Pérez de Soto Inmaculada, González Campos José, Prats-Martín Concepción, Bernal Ricardo, Vargas María Tere |
Targeted sequencing aids in identifying clonality in chronic myelomonocytic leukemia. Leukemia research 2019 Jul 84 106190. Hwang Sang Mee, Kim Sung-Min, Nam Youngwon, Kim Jinhyun, Kim Sungsik, Ahn Yong-Oon, Park Yong, Yoon Sung-Soo, Shin Sue, Kwon Sunghoon, Lee Dong So |
[Characterization of mutational pattern of patients with core-binding factor acute myeloid leukemia]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2019 Jul 36 (7): 657-661. He Jinyuan, Chao Hongying, Zhou Min, Lu Xuzhang, Chen Tao, Yang Jianhe, Jiang Naike, Zhang |
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms. Blood 2020 6 136 (16): 1851-1862. Palomo Laura, Meggendorfer Manja, Hutter Stephan, Twardziok Sven, Ademà Vera, Fuhrmann Irene, Fuster-Tormo Francisco, Xicoy Blanca, Zamora Lurdes, Acha Pamela, Kerr Cassandra M, Kern Wolfgang, Maciejewski Jaroslaw P, Solé Francesc, Haferlach Claudia, Haferlach Torst |
Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged?<60 years. Leukemia 2020 May . Eisfeld Ann-Kathrin, Kohlschmidt Jessica, Mims Alice, Nicolet Deedra, Walker Christopher J, Blachly James S, Carroll Andrew J, Papaioannou Dimitrios, Kolitz Jonathan E, Powell Bayard E, Stone Richard M, de la Chapelle Albert, Byrd John C, Mrózek Krzysztof, Bloomfield Clara |
Juvenile myelomonocytic leukemia - A bona fide RASopathy syndrome. Best practice & research. Clinical haematology 2020 5 33 (2): 101171. Lasho Terra, Patnaik Mrinal |
[Analysis of Clinical Features and Prognosis of Patients with Chronic Neutrophil Leukemia]. Zhongguo shi yan xue ye xue za zhi 2020 2 28 (1): 82-87. Guo Yu-Jie, Wang Yan, Wang Li-Hua, Zuo Ya-Bei, Niu Zhi-Yun, Lin Feng-Ru, Zhang Jing- |
Cytogenetic and molecular landscape and its potential clinical significance in Hispanic CMML patients from Puerto Rico. Oncotarget 2020 12 11 (47): 4411-4420. Jiang Zeju, Sun Xinlai, Wu Zhao, Alhatem Albert, Zheng Ruifang, Liu Dongfang, Wang Yaqun, Kumar Dibyendu, Xia Changqing, You Bei, Wang He, Liu Chen, Jiang Jie-G |
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia. HemaSphere 2020 11 4 (6): e497. Fontana Diletta, Ramazzotti Daniele, Aroldi Andrea, Redaelli Sara, Magistroni Vera, Pirola Alessandra, Niro Antonio, Massimino Luca, Mastini Cristina, Brambilla Virginia, Bombelli Silvia, Bungaro Silvia, Morotti Alessandro, Rea Delphine, Stagno Fabio, Martino Bruno, Campiotti Leonardo, Caocci Giovanni, Usala Emilio, Merli Michele, Onida Francesco, Bregni Marco, Elli Elena Maria, Fumagalli Monica, Ciceri Fabio, Perego Roberto A, Pagni Fabio, Mologni Luca, Piazza Rocco, Gambacorti-Passerini Car |
Differential U2AF1 mutation sites, burden and co-mutation genes can predict prognosis in patients with myelodysplastic syndrome. Scientific reports 2020 10 10 (1): 18622. Wang Haiqiong, Guo Yongbo, Dong Zhenkun, Li Tao, Xie Xinsheng, Wan Dingming, Jiang Zhongxing, Yu Jifeng, Guo Ro |
Impact of clinical features, cytogenetics, genetic mutations, and methylation dynamics of CDKN2B and DLC-1 promoters on treatment response to azacitidine. Annals of hematology 2020 1 99 (3): 527-537. Martín Iván, Navarro Blanca, Serrano Alicia, Villamón Eva, Calabuig Marisa, Solano Carlos, Chaves Felipe Javier, Yagüe Nuria, Orts Maribel, Amat Paula, Fuentes Azahara, Seda Enrique, García Francisca, Hernández-Boluda Juan Carlos, Tormo M |
Mutational landscape of chronic myelomonocytic leukemia and its potential clinical significance. International journal of hematology 2021 8 115 (1): 21-32. Han Wenmin, Zhou Feng, Wang Zheng, Hua Haiying, Qin Wei, Jia Zhuxia, Cai Xiaohui, Chen Meiyu, Liu Jie, Chao Hongying, Lu Xuzha |
CSF3R T618I, SETBP1 G870S, SRSF2 P95H, and ASXL1 Q780* tetramutation co-contribute to myeloblast transformation in a chronic neutrophilic leukemia. Annals of hematology 2021 Apr . Qian Yi, Chen Yan, Li Xiaomi |
Clinicopathologic correlates and natural history of atypical chronic myeloid leukemia. Cancer 2021 4 127 (17): 3113-3124. Montalban-Bravo Guillermo, Kanagal-Shamanna Rashmi, Sasaki Koji, Masarova Lucia, Naqvi Kiran, Jabbour Elias, DiNardo Courtney D, Takahashi Koichi, Konopleva Marina, Pemmaraju Naveen, Kadia Tapan M, Ravandi Farhad, Daver Naval, Borthakur Gautam, Estrov Zeev, Khoury Joseph D, Loghavi Sanam, Soltysiak Kelly A, Pierce Sherry, Bueso-Ramos Carlos, Patel Keyur P, Verstovsek Srdan, Kantarjian Hagop M, Bose Prithviraj, Garcia-Manero Guiller |
Mutations in chronic myelomonocytic leukemia and their prognostic relevance. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021 4 23 (9): 1731-1742. Jian J, Qiao Y, Li Y, Guo Y, Ma H, Liu |
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity. Blood cancer journal 2023 9 13 (1): 149. Talha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, James M Foran, Aref Al-Kali, Abhishek Mangaonkar, Hemant Murthy, Hassan B Alkhateeb, David Viswanatha, Rong He, Mithun Shah, Cecilia Arana Yi, Mark R Litzow, Naseema Gangat, Ayalew Tefferi, Mrinal M Patna |
Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition. European journal of haematology 2023 7 . Valentina Giudice, Bianca Serio, Santa Errichiello, Idalucia Ferrara, Alessandra Galdiero, Angela Bertolini, Roberta Visconti, Danilo De Novellis, Roberto Guariglia, Serena Luponio, Denise Morini, Anna Maria Della Corte, Anna Maria Sessa, Francesco Verdesca, Maddalena Langella, Barbara Izzo, Carmine Selle |
[Clinical characteristics and prognostic factors of patients with Philadelphia-negative myeloproliferative neoplasm accelerated/blast phase]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 6 44 (4): 276-283. X Yan, T J Qin, B Li, S Q Qu, L J Pan, F H Li, N N Liu, Z J Xiao, Z F |
Atypical CML: diagnosis and treatment. Hematology. American Society of Hematology. Education Program 2023 12 2023 (1): 476-482. Massimo Brecc |
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry. Cancers 2023 1 15 (2): . Sargas Claudia, Ayala Rosa, Larráyoz María José, Chillón María Carmen, Carrillo-Cruz Estrella, Bilbao-Sieyro Cristina, Prados de la Torre Esther, Martínez-Cuadrón David, Rodríguez-Veiga Rebeca, Boluda Blanca, Gil Cristina, Bernal Teresa, Bergua Juan Miguel, Algarra Lorenzo, Tormo Mar, Martínez-Sánchez Pilar, Soria Elena, Serrano Josefina, Alonso-Domínguez Juan Manuel, García-Boyero Raimundo, Amigo María Luz, Herrera-Puente Pilar, Sayas María José, Lavilla-Rubira Esperanza, Martínez-López Joaquín, Calasanz María José, García-Sanz Ramón, Pérez-Simón José Antonio, Gómez-Casares María Teresa, Sánchez-García Joaquín, Barragán Eva, Montesinos Pau, On Behalf Of Pethema Grou |
A comparative analysis of the clinical and genetic profiles of blast phase BCR::ABL1-negative myeloproliferative neoplasm and acute myeloid leukemia, myelodysplasia-related. International journal of laboratory hematology 2024 4 . Dong Chen, Julia Geyer, Adam Bagg, Robert Hasserjian, Olga K Weinbe |
- Page last reviewed:Feb 1, 2024
- Content source: